Dr. Reddy’s Laboratories’ U.S. subsidiary Promius Pharma LLC has received U.S. Food and Drug Administration approval for Sernivo (betamethasone dipropionate) spray (0.05%), a product used in the treatment of psoriasis.
The commercial launch of the product is planned for the coming quarter, said a Dr.Reddy’s release about receipt of the USFDA nod.
About Sernivo spray
Sernivo spray is a prescription topical steroid indicated for the treatment of mild to moderate plaque psoriasis in patients 18 years of age or older.
Current Affairs 8th February, 2016 Current Affairs Question and Answers Round Up January. Current Affairs Round up January, 2016.
Join The Discussion